Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Nephro Care India plans to raise Rs 35-40 crore via IPO

Ruchika Sharma27 May 2024 12:45 PM IST

Kolkata: Nephro Care India Ltd, a Kidney care provider said it plans to raise Rs 35-40 crore through an initial public offering (IPO)....

Sanofi gets USFDA fast track designation for neovascular age-related macular degeneration gene therapy

Sanofi Sarclisa accepted for USFDA priority review for transplant-ineligible newly diagnosed multiple myeloma

Ruchika Sharma27 May 2024 11:30 AM IST

Paris: Sanofi has announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License...

Malawi Ministry of Health, bioMerieux, Pfizer form multisectoral collaboration to help address antimicrobial resistance

Ruchika Sharma27 May 2024 9:00 AM IST

New York: The Malawi Ministry of Health, bioMerieux, and Pfizer have announced a collaboration to advance Malawi's first multisectoral initiative...

Mounjaro, Wegovy sales in India double on month in July

USFDA panel votes against Novo Nordisk weekly insulin use in type 1 diabetes patients

Ruchika Sharma26 May 2024 3:00 PM IST

Advisers to the U.S. health regulator cast their votes opposing the utilization of Novo Nordisk's weekly insulin for patients with type 1 diabetes,...

AbbVie seeks USFDA nod for combination regimen of Venclexta, Acalabrutinib

Caplin Steriles bags USFDA nod for Phenylephrine hydrochloride Ophthalmic Solution

Ruchika Sharma26 May 2024 1:00 PM IST

Phenylephrine hydrochloride Ophthalmic Solution USP 2.5% and 10% is indicated to dilate the pupil of the eyes.

Novartis, Arrowhead strike upto USD 2 billion deal for neuromuscular therapy license

Aktis Oncology partners Eli Lilly to discover, develop anticancer radiopharmaceuticals

Ruchika Sharma26 May 2024 11:30 AM IST

Boston: Aktis Oncology, a biotechnology company discovering and developing novel targeted radiopharmaceuticals to treat a broad range of solid...

Torrent Pharma to acquire 26% stake in Torrent Urja 27 for captive renewable power project

Torrent Pharma reports 56.45 percent jump in net profit to Rs 449 crore in Q4

Ruchika Sharma26 May 2024 10:00 AM IST

New Delhi: Torrent Pharmaceuticals Ltd witnessed a significant surge in its consolidated net profit, soaring by 56.45% to reach Rs 449 crore in...

Insufficient Efficacy, Safety Data: CDSCO Panel Rejects Zydus Phase III CT Waiver Request for Voclosporin

Zydus Lifesciences completes enrolment of Phase II clinical trial of Usnoflast in patients with Amyotrophic Lateral Sclerosis

Ruchika Sharma25 May 2024 12:50 PM IST

Usnoflast (ZYIL1) is a novel, oral small molecule NLRP3 inhibitor.

Unichem Labs Roha facility gets 3 USFDA observations

Aurobindo Pharma arm Unit III facility gets USFDA OAI status

Ruchika Sharma25 May 2024 12:32 PM IST

Hyderabad: Through a recent BSE filing, Aurobindo Pharma has informed that the United States Food and Drug Administration (US FDA) has determined...

Orchid Pharma announces Q4 results with 71.60 percent growth in annual PAT

Ruchika Sharma25 May 2024 10:00 AM IST

New Delhi: Orchid Pharma Ltd., a pharmaceutical company headquartered in Chennai, has announced a strong financial performance for the financial...

USFDA concludes audit at Cohance Lifesciences Jaggaiahpet facility

USFDA completes inspection at Gland Pharma Visakhapatnam facility with Zero 483 observations

Ruchika Sharma24 May 2024 4:33 PM IST

Telangana: Gland Pharma has informed in a BSE filing that the United States Food and Drug Administration (US FDA) has completed an...

Sun Pharma, Incyte settle dispute over LEQSELVI

Zantac not a cause of woman's cancer, says jury

Ruchika Sharma24 May 2024 3:34 PM IST

Chicago: A jury in Chicago delivered a verdict on Thursday, dismissing the claim of an Illinois woman who alleged that the discontinued...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok